Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO Consultation

The classification of diabetes mellitus and the tests used for its diagnosis were brought into order by the National Diabetes Data Group of the USA and the second World Health Organization Expert Committee on Diabetes Mellitus in 1979 and 1980. Apart from minor modifications by WHO in 1985, little has been changed since that time. There is however considerable new knowledge regarding the aetiology of different forms of diabetes as well as more information on the predictive value of different blood glucose values for the complications of diabetes. A WHO Consultation has therefore taken place in parallel with a report by an American Diabetes Association Expert Committee to re‐examine diagnostic criteria and classification. The present document includes the conclusions of the former and is intended for wide distribution and discussion before final proposals are submitted to WHO for approval. The main changes proposed are as follows. The diagnostic fasting plasma (blood) glucose value has been lowered to ≥7.0 mmol l−1 (6.1 mmol l−1). Impaired Glucose Tolerance (IGT) is changed to allow for the new fasting level. A new category of Impaired Fasting Glycaemia (IFG) is proposed to encompass values which are above normal but below the diagnostic cut‐off for diabetes (plasma ≥6.1 to <7.0 mmol l−1; whole blood ≥5.6 to <6.1 mmol l−1). Gestational Diabetes Mellitus (GDM) now includes gestational impaired glucose tolerance as well as the previous GDM. The classification defines both process and stage of the disease. The processes include Type 1, autoimmune and non‐autoimmune, with beta‐cell destruction; Type 2 with varying degrees of insulin resistance and insulin hyposecretion; Gestational Diabetes Mellitus; and Other Types where the cause is known (e.g. MODY, endocrinopathies). It is anticipated that this group will expand as causes of Type 2 become known. Stages range from normoglycaemia to insulin required for survival. It is hoped that the new classification will allow better classification of individuals and lead to fewer therapeutic misjudgements. © 1998 WHO

[1]  L. Bouter,et al.  The 1997 American Diabetes Association Criteria Versus the 1985 World Health Organization Criteria for the Diagnosis of Abnormal Glucose Tolerance: Poor agreement in the Hoorn Study , 1998, Diabetes Care.

[2]  Bruce M Psaty,et al.  Diabetes in older adults: comparison of 1997 American Diabetes Association classification of diabetes mellitus with 1985 WHO classification , 1998, The Lancet.

[3]  G. Berglund,et al.  Comparison of ADA and WHO criteria for diagnosis of diabetes and glucose intolerance , 1998, Diabetologia.

[4]  H. Lithell,et al.  Will new diagnostic criteria for diabetes mellitus change phenotype of patients with diabetes? Reanalysis of European epidemiological data , 1998 .

[5]  Ambady Ramachandran,et al.  Evaluation of the Use of Fasting Plasma Glucose as a New Diagnostic Criterion for Diabetes in Asian Indian Population , 1998, Diabetes Care.

[6]  M. Rowley,et al.  Autoantibodies to glutamic acid decarboxylase and phenotypic features associated with early insulin treatment in individuals with adult‐onset diabetes mellitus , 1998, Diabetic medicine : a journal of the British Diabetic Association.

[7]  Steno Diabetes.  Will new diagnostic criteria for diabetes mellitus change phenotype of patients with diabetes? Reanalysis of European epidemiological data. DECODE Study Group on behalf of the European Diabetes Epidemiology Study Group. , 1998, BMJ.

[8]  K. Flegal,et al.  Comparison of Diabetes Diagnostic Categories in the U.S. Population According to 1997 American Diabetes Association and 1980–1985 World Health Organization Diagnostic Criteria , 1997, Diabetes Care.

[9]  D. Turnbull,et al.  Mitochondrial related diabetes: a clinical perspective , 1997, Diabetic medicine : a journal of the British Diabetic Association.

[10]  W. Clarke,et al.  Early-onset type-ll diabetes mellitus (MODY4) linked to IPF1 , 1997, Nature Genetics.

[11]  M. Engelgau,et al.  Comparison of Fasting and 2-Hour Glucose and HbA1c Levels for Diagnosing Diabetes: Diagnostic criteria and performance revisited , 1997, Diabetes Care.

[12]  K. C. Samal,et al.  Overview and consensus statement on diabetes in tropical areas. , 1997, Diabetes/metabolism reviews.

[13]  T. Kuzuya,et al.  Classification of Diabetes on the Basis of Etiologies Versus Degree of Insulin Deficiency , 1997, Diabetes Care.

[14]  P. Zimmet,et al.  Epidemiology of NIDDM in Non-Europids , 1997 .

[15]  M. Fantone,et al.  Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus , 1997, Diabetes Care.

[16]  R. Hanson,et al.  Diagnosing diabetes mellitus – do we need new criteria? , 1997, Diabetologia.

[17]  B. Balkau,et al.  Revision of diagnostic criteria for diabetes , 1996, The Lancet.

[18]  T. Hansen,et al.  Mutations in the hepatocyte nuclear factor-1α gene in maturity-onset diabetes of the young (MODY3) , 1996, Nature.

[19]  M. Myers,et al.  Inhibition of Mitochondrial Complex I May Account for IDDM Induced by Intoxication With the Rodenticide Vacor , 1996, Diabetes.

[20]  A. Hattersley,et al.  Altered Insulin Secretory Responses to Glucose in Diabetic and Nondiabetic Subjects With Mutations in the Diabetes Susceptibility Gene MODY3 on Chromosome 12 , 1996, Diabetes.

[21]  K. Alberti.  The Clinical Implications of Impaired Glucose Tolerance , 1996, Diabetic medicine : a journal of the British Diabetic Association.

[22]  R. Rao,et al.  Malnutrition and Diabetes in the Tropics , 1996, Diabetes Care.

[23]  H. Chase,et al.  Prediction of Type I Diabetes in First-Degree Relatives Using a Combination of Insulin, GAD, and ICA512bdc/IA-2 Autoantibodies , 1996, Diabetes.

[24]  M. Rowley,et al.  Islet cell antibodies and antibodies against glutamic acid decarboxylase in newly diagnosed adult-onset diabetes mellitus. , 1996, Diabetes research and clinical practice.

[25]  J. Sturis,et al.  Seminars in Medicine of the Beth Israel Hospital, Boston. Non-insulin-dependent diabetes mellitus - a genetically programmed failure of the beta cell to compensate for insulin resistance. , 1996, The New England journal of medicine.

[26]  M. Stoffel,et al.  Mutations in the hepatocyte nuclear factor-4α gene in maturity-onset diabetes of the young (MODY1) , 1996, Nature.

[27]  T. Barrett,et al.  Neurodegeneration and diabetes: UK nationwide study of Wolfram (DIDMOAD) syndrome , 1995, The Lancet.

[28]  G. Umpierrez,et al.  Diabetic Ketoacidosis in Obese African-Americans , 1995, Diabetes.

[29]  C. Perronne,et al.  Pentamidine-Induced Derangements of Glucose Homeostasis: Determinant roles of renal failure and drug accumulation: A study of 128 patients , 1995, Diabetes Care.

[30]  J. Nerup,et al.  Incidence of Insulin‐dependent Diabetes Mellitus in Age Groups Over 30 years in Denmark , 1994, Diabetic medicine : a journal of the British Diabetic Association.

[31]  E. Seaquist,et al.  Insulin Sensitivity in Cystic Fibrosis , 1994, Diabetes.

[32]  M. Rowley,et al.  GAD Antibody Negative NIDDM in Adult Black Subjects with Diabetic Ketoacidosis and Increased Frequency of Human Leukocyte Antigen DR3 and DR4: Flatbush Diabetes , 1994, Diabetes.

[33]  R. Hanson,et al.  Comparison of tests for glycated haemoglobin and fasting and two hour plasma glucose concentrations as diagnostic methods for diabetes , 1994, BMJ.

[34]  M. Rowley,et al.  Latent Autoimmune Diabetes Mellitus in Adults (LADA): the Role of Antibodies to Glutamic Acid Decarboxylase in Diagnosis and Prediction of Insulin Dependency , 1994, Diabetic medicine : a journal of the British Diabetic Association.

[35]  T. Adrian,et al.  Islet amyloid polypeptide in patients with pancreatic cancer and diabetes. , 1994, The New England journal of medicine.

[36]  Rena R Wing,et al.  Caloric Restriction Per Se Is a Significant Factor in Improvements in Glycemic Control and Insulin Sensitivity During Weight Loss in Obese NIDDM Patients , 1994, Diabetes Care.

[37]  A. Peiris,et al.  Drug-Induced Disorders of Glucose Tolerance , 1993, Annals of Internal Medicine.

[38]  M. Harris,et al.  Undiagnosed NIDDM: Clinical and Public Health Issues , 1993, Diabetes Care.

[39]  M. G. Carlson,et al.  Impact of Obesity on Insulin Action in NIDDM , 1993, Diabetes.

[40]  P. Bennett,et al.  Determinants of Diabetes Mellitus in the Pima Indians , 1993, Diabetes Care.

[41]  Richard Barnett,et al.  Diabetes mellitus. , 1993, The Medical journal of Australia.

[42]  Simeon I. Taylor,et al.  Lilly Lecture: Molecular Mechanisms of Insulin Resistance: Lessons From Patients With Mutations in the Insulin-Receptor Gene , 1992, Diabetes.

[43]  S. Haffner,et al.  Prospective analysis of the insulin-resistance syndrome (syndrome X). , 1992, Diabetes.

[44]  J. Flier,et al.  Lilly Lecture: Syndromes of Insulin Resistance: From Patient to Gene and Back Again , 1992, Diabetes.

[45]  A. Floreani,et al.  Development of type 1 diabetes mellitus during interferon alfa therapy for chronic HCV hepatitis , 1992, The Lancet.

[46]  M. Stoffel,et al.  Nonsense mutation in the glucokinase gene causes early-onset non-insulin-dependent diabetes mellitus , 1992, Nature.

[47]  P. Zimmet.  Kelly West Lecture 1991 Challenges in Diabetes Epidemiology—From West to the Rest , 1992, Diabetes Care.

[48]  J. Beckmann,et al.  Close linkage of glucokinase locus on chromosome 7p to early-onset non-insulin-dependent diabetes mellitus , 1992, Nature.

[49]  P. Camilli,et al.  Autoimmunity to glutamic acid decarboxylase (GAD) in stiffman syndrome and insulin-dependent diabetes mellitus , 1991, Trends in Neurosciences.

[50]  P. Zimmet,et al.  Determining Diabetes Prevalence: a Rational Basis for the Use of Fasting Plasma Glucose Concentrations? , 1990, Diabetic medicine : a journal of the British Diabetic Association.

[51]  K. Alberti,et al.  Islet cell antibodies are not specifically associated with insulin-dependent diabetes in Tanzanian Africans. , 1990, Diabetes research and clinical practice.

[52]  P. Hall,et al.  PREVALENCE OF GENETIC HAEMOCHROMATOSIS AMONG DIABETIC PATIENTS , 1989, The Lancet.

[53]  N. Kaplan.  The deadly quartet. Upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension. , 1989, Archives of internal medicine.

[54]  G. Reaven.  Role of Insulin Resistance in Human Disease , 1988, Diabetes.

[55]  Ji-Woon Yoon,et al.  ASSOCIATION OF CYTOMEGALOVIRUS INFECTION WITH AUTOIMMUNE TYPE 1 DIABETES , 1988, The Lancet.

[56]  H. Beck-Nielsen,et al.  Classification of Newly Diagnosed Diabetic Patients as Insulin-Requiring or Non—Insulin-Requiring Based on Clinical and Biochemical Variables , 1988, Diabetes Care.

[57]  S. Efendić.  Pathogenesis of NIDDM. , 1988, Diabetes research and clinical practice.

[58]  S. Larsen,et al.  Metabolic control and B cell function in patients with insulin-dependent diabetes mellitus secondary to chronic pancreatitis. , 1987, Metabolism: clinical and experimental.

[59]  P. Grant,et al.  ISLET-CELL ANTIBODIES AND INSULIN AUTOANTIBODIES IN ASSOCIATION WITH COMMON VIRAL INFECTIONS , 1986, The Lancet.

[60]  G. Bell,et al.  Prevalence of insulin-gene mutations in non-insulin-dependent diabetes mellitus. , 1986, The New England journal of medicine.

[61]  B. Ahrén,et al.  Intermittent need for insulin in a subgroup of diabetic patients in Tanzania. , 1985, Diabetic medicine : a journal of the British Diabetic Association.

[62]  S. Lillioja,et al.  Relationship between degree of obesity and in vivo insulin action in man. , 1985, The American journal of physiology.

[63]  P. Gorden,et al.  Lupus nephritis and other autoimmune features in patients with diabetes mellitus due to autoantibody to insulin receptors. , 1985, Annals of internal medicine.

[64]  P. Gruppuso,et al.  Familial hyperproinsulinemia due to a proposed defect in conversion of proinsulin to insulin. , 1984, The New England journal of medicine.

[65]  K. Polonsky,et al.  Familial hyperinsulinemia due to a structurally abnormal insulin. Definition of an emerging new clinical syndrome. , 1984, The New England journal of medicine.

[66]  S. Shoelson,et al.  Familial hyperproinsulinemia. Two cohorts secreting indistinguishable type II intermediates of proinsulin conversion. , 1984, The Journal of clinical investigation.

[67]  R. DeFronzo,et al.  Mechanism of improvement in glucose metabolism after chronic glyburide therapy. , 1984, Diabetes.

[68]  A. Voller,et al.  COXSACKIE-B-VIRUS-SPECIFIC IgM RESPONSES IN CHILDREN WITH INSULIN-DEPENDENT (JUVENILE-ONSET; TYPE I) DIABETES MELLITUS , 1983, The Lancet.

[69]  A. Kissebah,et al.  Relation of body fat distribution to metabolic complications of obesity. , 1982, The Journal of clinical endocrinology and metabolism.

[70]  M. V. Varas Lorenzo.  [Somatostatinoma syndrome]. , 1982, Medicina clinica.

[71]  M. Shipley,et al.  CORONARY-HEART-DISEASE RISK AND IMPAIRED GLUCOSE TOLERANCE The Whitehall Study , 1980, The Lancet.

[72]  WHO Expert Committee on Diabetes Mellitus: second report. , 1980, World Health Organization technical report series.

[73]  Classification and Diagnosis of Diabetes Mellitus and Other Categories of Glucose Intolerance , 1979, Diabetes.

[74]  C. Kahn,et al.  Effects of autoantibodies to the insulin receptor on isolated adipocytes. Studies of insulin binding and insulin action. , 1977, The Journal of clinical investigation.

[75]  C. Kahn,et al.  The syndromes of insulin resistance and acanthosis nigricans. Insulin-receptor disorders in man. , 1976, The New England journal of medicine.

[76]  M. Menser,et al.  High frequency of diabetes mellitus in young adults with congenital rubella. , 1971, Lancet.

[77]  J. Conn.  Hypertension, the potassium ion and impaired carbohydrate tolerance. , 1965, The New England journal of medicine.